HARTE-HANKS INC (HHS) Fundamental Analysis & Valuation

NASDAQ:HHS • US4161962026

Current stock price

2.37 USD
+0 (+0.21%)
Last:

This HHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HHS Profitability Analysis

1.1 Basic Checks

  • In the past year HHS has reported negative net income.
  • HHS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: HHS reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: HHS reported negative operating cash flow in multiple years.
HHS Yearly Net Income VS EBIT VS OCF VS FCFHHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

  • With a Return On Assets value of -5.87%, HHS perfoms like the industry average, outperforming 46.74% of the companies in the same industry.
  • HHS has a Return On Equity (-27.38%) which is in line with its industry peers.
  • The Return On Invested Capital of HHS (5.20%) is better than 69.57% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HHS is above the industry average of 6.70%.
  • The last Return On Invested Capital (5.20%) for HHS is well below the 3 year average (11.42%), which needs to be investigated, but indicates that HHS had better years and this may not be a problem.
Industry RankSector Rank
ROA -5.87%
ROE -27.38%
ROIC 5.2%
ROA(3y)-0.52%
ROA(5y)1.66%
ROE(3y)13.57%
ROE(5y)N/A
ROIC(3y)11.42%
ROIC(5y)N/A
HHS Yearly ROA, ROE, ROICHHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

  • With a Operating Margin value of 2.35%, HHS perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
  • HHS's Operating Margin has declined in the last couple of years.
  • HHS's Gross Margin of 18.47% is on the low side compared to the rest of the industry. HHS is outperformed by 73.91% of its industry peers.
  • HHS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.35%
PM (TTM) N/A
GM 18.47%
OM growth 3Y-16.84%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y15.62%
HHS Yearly Profit, Operating, Gross MarginsHHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. HHS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HHS is creating some value.
  • Compared to 1 year ago, HHS has more shares outstanding
  • HHS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HHS has a worse debt to assets ratio.
HHS Yearly Shares OutstandingHHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
HHS Yearly Total Debt VS Total AssetsHHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • HHS has an Altman-Z score of 14.54. This indicates that HHS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HHS (14.54) is better than 97.83% of its industry peers.
  • HHS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.03, HHS belongs to the top of the industry, outperforming 81.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 14.54
ROIC/WACC0.58
WACC8.96%
HHS Yearly LT Debt VS Equity VS FCFHHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

2.3 Liquidity

  • A Current Ratio of 1.48 indicates that HHS should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.48, HHS perfoms like the industry average, outperforming 57.61% of the companies in the same industry.
  • HHS has a Quick Ratio of 1.48. This is a normal value and indicates that HHS is financially healthy and should not expect problems in meeting its short term obligations.
  • HHS has a Quick ratio (1.48) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
HHS Yearly Current Assets VS Current LiabilitesHHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. HHS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 82.08% over the past year.
  • Looking at the last year, HHS shows a very negative growth in Revenue. The Revenue has decreased by -11.07% in the last year.
  • Measured over the past years, HHS shows a decrease in Revenue. The Revenue has been decreasing by -3.17% on average per year.
EPS 1Y (TTM)82.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1641.5%
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-1.63%
Revenue growth 5Y-3.17%
Sales Q2Q%-17.03%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y131.2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HHS Yearly Revenue VS EstimatesHHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
HHS Yearly EPS VS EstimatesHHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

4

4. HHS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HHS. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 2.19 indicates a rather cheap valuation of HHS.
  • HHS's Price/Forward Earnings ratio is rather cheap when compared to the industry. HHS is cheaper than 96.74% of the companies in the same industry.
  • HHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.19
HHS Price Earnings VS Forward Price EarningsHHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HHS is valued cheaper than 98.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.37
HHS Per share dataHHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HHS Dividend Analysis

5.1 Amount

  • No dividends for HHS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HHS Fundamentals: All Metrics, Ratios and Statistics

HARTE-HANKS INC

NASDAQ:HHS (3/27/2026, 8:23:31 PM)

2.37

+0 (+0.21%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-12
Earnings (Next)05-12
Inst Owners31.25%
Inst Owner Change-1.99%
Ins Owners38.21%
Ins Owner Change0%
Market Cap17.56M
Revenue(TTM)166.84M
Net Income(TTM)-5.44M
Analysts80
Price TargetN/A
Short Float %1%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.19
P/S 0.11
P/FCF N/A
P/OCF 11.2
P/B 0.88
P/tB 0.92
EV/EBITDA 1.37
EPS(TTM)-0.74
EYN/A
EPS(NY)1.08
Fwd EY45.6%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.21
OCFY8.93%
SpS22.52
BVpS2.68
TBVpS2.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.87%
ROE -27.38%
ROCE 6.58%
ROIC 5.2%
ROICexc 5.83%
ROICexgc 5.91%
OM 2.35%
PM (TTM) N/A
GM 18.47%
FCFM N/A
ROA(3y)-0.52%
ROA(5y)1.66%
ROE(3y)13.57%
ROE(5y)N/A
ROIC(3y)11.42%
ROIC(5y)N/A
ROICexc(3y)13.82%
ROICexc(5y)N/A
ROICexgc(3y)14.26%
ROICexgc(5y)N/A
ROCE(3y)14.46%
ROCE(5y)N/A
ROICexgc growth 3Y-19.31%
ROICexgc growth 5YN/A
ROICexc growth 3Y-19.72%
ROICexc growth 5YN/A
OM growth 3Y-16.84%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y15.62%
F-Score6
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.06
Cap/Depr 42.46%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 18.33%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 14.54
F-Score6
WACC8.96%
ROIC/WACC0.58
Cap/Depr(3y)122.2%
Cap/Depr(5y)111.4%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1641.5%
EPS Next Y131.2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-1.63%
Revenue growth 5Y-3.17%
Sales Q2Q%-17.03%
Revenue Next Year4.05%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-57.2%
EBIT growth 3Y-18.2%
EBIT growth 5YN/A
EBIT Next Year198.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-103.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.56%
OCF growth 3YN/A
OCF growth 5YN/A

HARTE-HANKS INC / HHS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HARTE-HANKS INC (HHS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HHS.


What is the valuation status for HHS stock?

ChartMill assigns a valuation rating of 4 / 10 to HARTE-HANKS INC (HHS). This can be considered as Fairly Valued.


What is the profitability of HHS stock?

HARTE-HANKS INC (HHS) has a profitability rating of 4 / 10.


Can you provide the financial health for HHS stock?

The financial health rating of HARTE-HANKS INC (HHS) is 4 / 10.